甲基化合成致死性:利用选择性药物点进行癌症治疗
Bing-Jie Ye1, Di-Fei Li1, Xin-Yun Li1
1Clinical Medicine, The Fourth Affiliated Hospital of China Medical University, Shenyang 110032, China.
Cancer letters
|June 7, 2024
概括
甲基化合成致死性利用癌症特异性表观遗传变化进行向治疗. 这种方法使用药物来抑制基因,导致癌细胞死亡,同时保留正常细胞,为癌症治疗提供了一个有前途的新途径.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 合成致死性通过将基因抑制与药物诱导的无活化相结合,提供向的癌细胞杀死.
- 异常的表观遗传变化,特别是甲基化,越来越多地被认为是某些癌症的常见驱动因素.
- 甲基化合成杀伤性利用这些表观遗传变化获得治疗效益.
研究的目的:
- 系统地审查甲基化合成致死性在癌症治疗中的优势.
- 在细胞模型中描述成功甲基化合成致命组合的致命机制.
- 讨论这种向治疗方法的未来机会和挑战.
主要方法:
- 对有关甲基化合成致死性的最新文献进行系统审查.
- 对表现出成功合成致命组合的细胞模型的分析.
- 对有前途的候选人进行临床试验数据的检查.
主要成果:
- 甲基化合成致命性在涉及DNA损伤修复和代谢途径基因的细胞模型中取得了显著的成功.
- 几种甲基化合成致命组合已经进入临床试验,结果令人鼓舞.
- 该方法通过利用表观遗传脆弱性,专门针对癌细胞.
结论:
- 甲基化合成致死性为向抗癌疗法提供了一个强大的策略.
- 了解这些组合的机制是优化它们有效性的关键.
- 进一步的研究和临床试验对于克服挑战和充分实现这种治疗范式的潜力至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Phase II Reactions: Methylation Reactions
177
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
177
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K


